to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence.
Operational tolerance in clinical liver transplantation: emerging developments.
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up.
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months.
Finding the right time for weaning off immunosuppression in solid organ transplant recipients.
Clinical operational tolerance after renal transplantation: current status and future challenges.
How regenerative medicine may contribute to the achievement of an immunosuppression-free state.
Immunosuppression-free transplantation reconsidered from a regenerative medicine perspective.
Immunoisolation: where regenerative medicine meets solid organ transplantation.
Esophageal tissue engineering: a new approach for esophageal replacement.
Organ bioengineering and regeneration as the new Holy Grail for organ transplantation.
Will regenerative medicine replace transplantation?
Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective.
Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study.
Semi-xenotransplantation: the regenerative medicine-based approach to immunosuppression-free transplantation and to meet the organ demand.
The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients.